Posts Tagged ‘Funding’
Clee Medical Secures Seed Funding to Advance Real-Time Brain Imaging Technology
Clee Medical, a Geneva-based neurotechnology startup, has successfully closed its Seed financing round to accelerate the development of its ultra-high-resolution real-time imaging platform for brain surgery. The round was led by High-Tech Gründerfonds (HTGF), with participation from Zürcher Kantonalbank (ZKB), Kickfund, FONGIT, Venture Kick, and continued support from Wyss Geneva. At the core of the…
Read MoreNose Switzerland Gets a FIF Seed Impact Grant
Nose Switzerland is addressing malnutrition in cancer patients with taste and smell disorders. The project got a CHF 20,000 FIF Seed Impact Grant. Developed in close collaboration with researchers from Hôpitaux Universitaires de Genève (HUG) and Université de Genève (UNIGE), Nose Switzerland addresses a pressing but often overlooked consequence of cancer treatment: chemosensory dysfunction. Patients who undergo…
Read MoreSwiss Biotech HemostOD Secures CHF 2 Million Innosuisse Grant to Advance Universal Platelet Technology
Swiss Health Valley biotech company HemostOD has been awarded a CHF 2 million competitive grant from Innosuisse, the Swiss Innovation Agency, to support key development milestones for its groundbreaking platelet manufacturing platform. The non-dilutive funding will play a pivotal role in strengthening HemostOD’s financial position as it moves towards major value-inflection points, including progressing toward…
Read MorePfizer Prize: HUG, UNIL and UNIFR Researchers Awarded
Three Swiss Health Valley research projects have been awarded the Prix Pfizer de la recherche biomédicale 2026, showcasing innovation across cancer immunotherapy, digital health, and personalized medicine. Each project received a CHF 20,000 grant. Personalized cancer vaccine – HUGA research team led by Nicolas Mach, together with Rémi Vernet and Eugenio Fernandez at the HUG…
Read MoreVi Partners announces first close of its new CHF 150 million fund
The first close coincides with the 25th anniversary of Vi Partners, marking a quarter-century of continuous venture capital activity. Since its founding in 2001, Vi Partners has supported successive generations of entrepreneurs and contributed to the development of Switzerland as a leading hub for technology and healthcare innovation. Building on more than two decades of…
Read More4 New FIT Tech Grants To Life Sciences Projects
Four projects have received support from the Foundation for Innovation and Technology (FIT) in the form of CHF 100’000 Tech Grants: PreciMune and Tamaro Bioscience from CHUV, and Germion Therapeutics and Obstetrical Care Solutions from EPFL will be able to continue developing their technologies with the backing of the Foundation. PreciMune delivers superior immune profiling…
Read MoreDistalmotion Secures Investment From J&J
The Biopôle-based global MedTech company, which created the surgeon robot Dexter announced a strategic investment from Johnson & Johnson.
Read MoreNourishAI, GenoRobotics and Infera Neuro Get Support from the EPFL Startup Launchpad
Three EPFL-born startups receive key funding to advance breakthrough technologies in health and biology.
Read MoreReverso Therapeutics Secures CHF 710,000 Innosuisse Grant
Reverso Therapeutics, a University of Geneva (UNIGE) pharmaceutical spin-off, and winner of the Bioinnovation Day Best Academic Project Award 2025, has been awarded a CHF 710,000 grant from Innosuisse to accelerate the development of its breakthrough reversible anticoagulant technology.
Read MoreDatabaum and Lemna Bio Receive a Tech Seed Loan from FIT
Two Tech Seed loans of CHF 100,000 each were awarded by FIT to Databaum , an artificial intelligence platform for farmers that transforms raw data from the field into intelligent decisions; and to Lemna Bio, where artificial intelligence is used to understand biological interactions. databaum: data intelligence for regenerative agriculture Agriculture can only be truly…
Read More